# Ginkgo Bioworks Holdings, Inc. (DNA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Ginkgo Bioworks Holdings, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/DNA/mda/fy2025/): filed 2026-02-26; accession 0001628280-26-012346 (https://www.sec.gov/Archives/edgar/data/1830214/000162828026012346/dna-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/DNA/mda/fy2024/): filed 2025-02-25; accession 0001628280-25-007819 (https://www.sec.gov/Archives/edgar/data/1830214/000162828025007819/dna-20241231.htm)
- [FY 2023 MD&A](/company/DNA/mda/fy2023/): filed 2024-02-29; accession 0001628280-24-008052 (https://www.sec.gov/Archives/edgar/data/1830214/000162828024008052/dna-20231231.htm)
- [FY 2022 MD&A](/company/DNA/mda/fy2022/): filed 2023-03-13; accession 0000950170-23-007461 (https://www.sec.gov/Archives/edgar/data/1830214/000095017023007461/dna-20221231.htm)
- [FY 2021 MD&A](/company/DNA/mda/fy2021/): filed 2022-03-29; accession 0000950170-22-004821 (https://www.sec.gov/Archives/edgar/data/1830214/000095017022004821/dna-20211231.htm)

Back to /company/DNA/